TXG

$32.04-$1.07 (-3.25%)live

Held · Bookmarked

0 · 0

portfolios · users

Platform exposure

13F filers

2

institutions

Market cap

$4.0B

127M shares

52-week range

$10.63 – $36.59

82% from low

Sector

LABORATORY ANALYTICAL INSTRUMENTS

Exchange

NASDAQ

CS

Borrow rate

0.25%

Easy to borrow

Price (6 mo)

Loading chart…
Change$-157.86

10x Genomics, Inc. Class A Common Stock

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

www.10xgenomics.com
Employees
1,178
IPO / List date
Sep 12, 2019
HQ
PLEASANTON, CA

Held by traders on TradeandTell

No one on the platform currently holds TXG.

Super investors & insiders

Institutions holding (13F)
InstitutionSharesReported
Renaissance Technologiesas of 2025-09-301,044,921$12.2M
Bridgewater Associatesas of 2026-03-3135,101$745.2K
Insider activity (SEC Form 4)

Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.

Recent trades on TradeandTell

No one on the platform has traded TXG yet.

$TXG chatter on StockTwits

  • MikeCaymanTrades@MikeCaymanTrades3d

    $TXG - Massive broadening wedge from last April. 6.78 to 34.76

    View on StockTwits ↗
  • Sean@seannystockrockets5d

    $TXG and $HIMS both look great and now around $35. looking for some big upside potnetial with market cooperation.

    View on StockTwits ↗
  • p raa@egcgfiend5d

    $PACB $TXG

    View on StockTwits ↗
  • p raa@egcgfiendBullish5d

    $PACB Oh look, Nanopore still has fundamental, physically entrenched accuracy issues (they were a fraud and we always knew it) In Pilot Study, Oxford Nanopore Shows Promise for Rare Disease Testing but Misses Some CNVs : GOTHENBURG, Sweden – Researchers at University Medical Center Utrecht in the Netherlands have found that Oxford Nanopore's sequencing technology is promising for rare genetic disease testing, but still needs to improve its ability to correctly call diagnostically relevant copy number variants, along with better data visualization and quality control tools. $TXG 10x is rock solid tech and has a great future but it is apples to oranges with $PACB which will also run soon, once we shake off a few crusty short seller 'tards

    View on StockTwits ↗
  • Greg Musk@JMJTradingBullish6d

    $GDHG all in here! Very bouncy! Should get some attn for being a micro float and primed to run to $TXG $PAVS $CRVO $OBAI

    View on StockTwits ↗
  • Greg Musk@JMJTradingBullishJun 16

    $CRVO A new solid base was just formed at $5. This will launch into a reversal - Follow for more. SL at $4.98 - Sell at $TXG $SUGP $QTEX

    View on StockTwits ↗
  • Morgan Horatio@MorganHoratioJun 9

    During this market downturn, please pay attention to the following stocks: Health: $ABCL $VKTX $HIMS $TXG $CRSP An exceptional high-alpha radar for the healthcare sector! This local macro consolidation is providing a premium entry zone for true clinical disrupters and digital health compounders. The fundamental catalysts driving this group are deeply institutional. HIMS is a standout hyper-growth monster, surging over 6% into the $28 node backed by relentless expansion in its customized weight-loss workstreams and explosive net income inflections. VKTX represents an elite macro-accumulation play ahead of its critical oral obesity data milestones, while CRSP and TXG (10x Genomics) lock in structural, irreplaceable moats across gene-editing and spatial biology instrumentation. As capital rotates into high-conviction health tech, are you compounding shares in the immediate cash-flow powerhouse HIMS, or front-running the technical floors on VKTX and CRSP?

    View on StockTwits ↗
  • Mike Krause@WalterWhite13BullishJun 9

    $TXG

    View on StockTwits ↗
  • DiamondHandsDO@DiamondHandsDOJun 8

    $TXG load up!

    View on StockTwits ↗
  • Estimize@EstimizeJun 8

    Wall St is expecting -0.23 EPS for $TXG Q2 [Reporting 08/06 AMC] http://www.estimize.com/intro/txg?chart=historical&metric_name=eps&utm_con

    View on StockTwits ↗
  • jacob mintz@jacobmintzJun 5

    Cabot Options Trader Call Buying Activity: $TXG $TEM $NBIS $QCOM $NOK

    View on StockTwits ↗
  • 🐺 WOLFIE@WOLFSTREETJun 4

    $TXG WHAT A DAY ON A GREAT STOCK! Too soon for CC to be doing this?

    View on StockTwits ↗
  • Maverik@MaverikITJun 4

    @Jblack500 @No_Face_character @WAJeff @cynicaloptimist @IsabellaDC @BustaCapital $NTRA $TWST $TXG

    View on StockTwits ↗
  • Maverik@MaverikITBullishJun 4

    @Jblack500 @No_Face_character @WAJeff @cynicaloptimist @IsabellaDC @BustaCapital Doing da twist$ ? $TWST $TXG $NTRA

    View on StockTwits ↗
  • Maverik@MaverikITJun 4

    @Jblack500 @No_Face_character @WAJeff @cynicaloptimist @IsabellaDC @BustaCapital Needing to check anything? $NTRA $TEM $TXG $WGS

    View on StockTwits ↗

Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.